NMDA Receptors in Astrocytes

  • Neurochem Res. 2020 Jan;45(1):122-133. doi: 10.1007/s11064-019-02750-3.
Alexei Verkhratsky  1  2  3 ,  Alexandr Chvátal  4  5
Affiliations
  • 1. Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK. [email protected].
  • 2. Achucarro Center for Neuroscience, IKERBASQUE, Basque Foundation for Science, 48011, Bilbao, Spain. [email protected].
  • 3. Center for Basic and Translational Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark. [email protected].
  • 4. LBCC Healthcare s.r.o, Prague, Czech Republic. [email protected].
  • 5. Institute of Pharmacology and Toxicology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. [email protected].
Abstract

Astrocytes support glutamatergic neurotransmission in the central nervous system through multiple mechanisms which include: (i) glutamate clearance and control over glutamate spillover due to operation of glutamate transporters; (ii) supply of obligatory glutamate precursor glutamine via operation of glutamate-glutamine shuttle; (iii) supply of L-serine, the indispensable precursor of positive NMDA receptors neuromodulator D-serine and (iv) through overall homoeostatic control of the synaptic cleft. Astroglial cells express an extended complement of ionotropic and Metabotropic Glutamate Receptors, which mediate glutamatergic input to astrocytes. In particular a sub-population of astrocytes in the cortex and in the spinal cord express specific type of NMDA receptors assembled from two GluN1, one GluN2C or D and one GluN3 subunits. This composition underlies low Mg2+ sensitivity thus making astroglial NMDA receptors operational at resting membrane potential. These NMDA receptors generate ionic signals in astrocytes and are linked to several astroglial homoeostatic molecular cascades.

Keywords
Astrocyte; Glutamate; NMDA receptors; Neurotransmitters.